Pacira BioSciences in its response to a proxy fight by DOMA Perpetual Capital Management

On March 14, 2025, Pacira BioSciences, Inc. confirmed that DOMA Perpetual Capital Management LLC has nominated three candidates to stand for election to the Pacira Board of Directors at the Company’s 2025 Annual Meeting.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Pacira BioSciences.